News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Mohamad Mohty shares long-term survival outcomes from the phase II MagnetisMM-3 study – Multiple Myeloma Hub
Photo from Mohamad Mohty/X
Jun 20, 2024, 11:53

Mohamad Mohty shares long-term survival outcomes from the phase II MagnetisMM-3 study – Multiple Myeloma Hub

Multiple Myeloma Hub shared on X/Twitter:

“CONGRESS | POSTER | EHA2024 | Mohamad Mohty shares long-term survival outcomes from the phase II MagnetisMM-3 study of elranatamab in patients with RRMM, N=123. ORR remained at 61%, with median DoR not reached.”

Source: Multiple Myeloma Hub/X

cancer EHA2024 elranatamab MagnetisMM-3 Mohamad Mohty Multiple Myeloma Hub OncoDaily Oncology RRMM
Blog
Aug 9, 2024, 18:07
5th Scientific Workshop - ESHMICRO2025
Insight
Aug 9, 2024, 18:04
Meyer May-Lucie: New publication in The Lancet reviewing the treatment of advanced lung cancer
Insight
Aug 9, 2024, 17:56
Yu Fujiwara: ASCO Breakthrough to Highlight Advances in Esophageal, Nasopharyngeal, Lung Cancers
Blog
Aug 9, 2024, 17:54
Robin Zon: Wonderful first day of ASCOBT24
Insight
Aug 9, 2024, 17:49
Soraia Lobo-Martins: Tumour Heterogeneity in Molecular Imaging for Breast Cancer
Insight
Aug 9, 2024, 17:49
Cancer survivors are at a significant risk of CVD-related mortality
Blog
Aug 9, 2024, 17:27
Kimryn Rathmell: Our gold medals are the scientific advances that give someone more time with their loved ones
Insight
Aug 9, 2024, 17:20
Denis Wirtz: Taking a precancerous lesion for a spin
Insight
Aug 9, 2024, 17:20
Hyun Kim: Y-90 in arterially hypoperfused tumors in primary hepatic malignancies
Blog
Aug 9, 2024, 17:12
Annual Teddy Bear Clinic of the Children's Cancer Hospital at MD Anderson Cancer Center
Insight
Aug 9, 2024, 16:57
Khalid El Bairi: Jewel edited by Sarah Elaine Eaton - The Second Hand Book of Academic Integrity
Blog
Aug 9, 2024, 16:38
Albert Koong: PFS of 10.3 month vs. 2.5 month in Pancreas Cancer patients with oligometastatic disease